Screening of Antimicrobial
Potential and Phytoconsituents for Different Extracts
of Memecylon umbellatum Burm Inflorescences
Suresh G. Killedar*and Harinath N. More
Department of
Pharmacognosy, Bharati Vidyapeeth
College of Pharmacy, Kolhapur (M.S.) India
*Corresponding Author E-mail: sureshgk_64@rediffmail.com
ABSTRACT:
The plant Memecylon umbellatum Burm
is small tree or shrub with beautiful purple inflorescences. Various other
parts of the plant were studied for different medicinal properties but no
scientific data on inflorescence except the description about its beauty and
photographs. Hence in the present work efforts have been made to investigate
antimicrobial properties and phytochemical screening of the inflorescence.
Six different extracts with non polar and
polar solvents were screened for antimicrobial activity by cylinder cup plate
method using standard cultures (ATCC), MIC by serial broth dilution and
phytochemical screening was made with different chemical reagents. Ethyl acetate and methanol extracts have
shown better activities compare to other extracts and were found significant compare
to control and standard at tested concentrations. MIC for ethyl acetate and
methanol extract was found at 0.5mg for most of the test organisms compare to 3
and 6mg for other extracts. All other extracts have shown very weak activity as
compare to standard even at higher concentrations. Most of the non polar
extracts showed almost negligible anti fungal and very weak antibacterial
activities. Different extracts showed presence of tannins, glycosides, triterpens and steroids as important constituents.
KEYWORDS:
Antimicrobial,
Phytochemical screening, Memecylon umbellatum, cylinder cup plate method.
INTRODUCTION:
Many efforts
have been made to discover new antimicrobial compounds from various kinds of
sources such as micro-organisms, animals, and plants. One of such resources is
folk medicines. Systematic screening of them may result in the discovery of
novel effective compounds (Tomoko et al. 2002)1. The
increasing prevalence of multidrug resistant strains of bacteria and the recent
appearance of strains with reduced susceptibility to antibiotics raises the
specter of untreatable bacterial infections and adds urgency to the search for
new infection-fighting strategies (Sieradski et al.
1999)2. Many microorganisms can cause several diseases and in spite
of the tremendous advancement of medical science and technology, diseases are
the leading health problem particularly in the under privileged population in
the remote rural areas in the developing countries.
Nature has
been a source of medicinal agents for thousands of years and an impressive
number of modern drugs have been isolated from natural sources, many based on
their use in traditional medicine. Medicinal plants are used locally in the
treatment of infections caused by fungi, bacteria, viruses and parasites and
over 60% of people in Nigeria rural areas depend on the traditional medicine
for the treatment of their ailments (Ghani et al., 1989)3.
Different plants have been used as a source of inspiration in the development
of novel drugs (Robbers et al., 1996)4. Plant derived medicines are
widely used because they are relatively safer than the synthetic alternatives,
they are easily available and cheaper (Iwu et al.,
1999)5. Many plant species have been evaluated for their
antimicrobial activity in the past 20 years (Castello
et al., 2000)6. Since then efficacy of many medicinal plants in the
treatment of many diseases have been put to test in many laboratories (Shajahan and Ramesh, 2004)7.
Memecylon umbellatum Burm. (Family: Melastomataceae)
is small evergreen shrub or tree having young terete
branches and bears numerous umbellate cymes. The plant is known as “Anjani” in Sanskrit and “Ironwood tree” in English. Plants
are distributed mostly in coastal regions of the Deccan peninsula, the eastern
and southern part of India all along Western Ghats and in the Andaman islands.8,
9. The leaves have been reported to possess astringent properties and are
given to treat leucorrhoea and gonorrhoea. Lotion
prepared from leaves is used to treat eye troubles. The decoction of the root
is used in the treatment of excessive menstrual discharge.10 Leaves
are also reported to possess antiviral activity.11 Bark is used in
the treatment of bruises externally as lepa along
with coconut kernels (Dymock).The literature survey
reveal that leaves and roots of Memecylon umbellatum have been investigated for its hypoglycemic
activity using alloxan induced hyperglycemic wistar albino rats.12, 13 Wound healing activity
of ethanolic extract of leaves has also been
reported.14 Root of the plant has been reported for antipyretic,
analgesic and anti-inflammatory, hepatoprotective, anthelmintic and anti-insect activities.15-18 Plant
contains wide variety of phytoconstituents such as umbellactone, amyrine, oleanolic acid, ursolic acid, sitosterol and organic acids. 19, 20
Taking into
account that the mostly leaves and root of the plant have been studied but no
literature on medicinal property of inflorescence is reported. Hence the
present study was planned to explore any possible potential of Memecylon umbellatum (MU)
inflorescence extracts along with phytochemical investigation.
MATERIALS AND METHODS:
Materials:
The
inflorescences of Memecylon umbellatum were collected in the month of March-April
from Gaganbavada region (Kolhapur Dist.),
Maharashtra, India. The plant material was taxonomically indentified by Dr. S.
R. Yadav, Department of Botany, Shivaji
University, Kolhapur, (M.S.). The voucher specimen (SGK-1) is deposited in
department of Pharmacognosy, Bharati Vidyapeeth College of Pharmacy, Kolhapur. Microbial
cultures were procured from NCIM Pune, Culture media
from Hi-Media and all the reagents and chemicals used were of AR grade (Loba, S.D. Fine, and Merck)
Methods:
Collection drying and powdering of plant
material:
Inflorescences
were collected in the month of March-April and dried under shade for one week.
Dried sample was powdered using electric blender (Bajaj) and fine powder was
obtained by passing through # 80. Powder sample (1kg) was used for extraction.
Soxhlet extraction and Evaluation of
Extracts 21-23
Air dried powder sample (1Kg) was used for extraction. Sample powder
was packed gently in previously washed and dried cloth bag and solvent was
placed from top with the help of funnel to moisten the drug sample. 3.5lit of
solvent was placed in distillation flask and assembly was made air tight with
sealing wax. Solvents were selected on the basis of extractive values and with
their increasing order of polarity. Extraction was carried out at or slightly
above the boiling point of each solvent using thermostatic heating mantle for
18h or on the basis of clarity of dropping solvent (saturation). The solvent
was collected every time after completion of process and powder was dried in
hot air oven for 24h at 450C. The process was repeated for all the
next solvents and finally the dried powder was macerated for 48h with 3.5 lit.
of chloroform water IP (0.25% v/v) at room temperature in macerating bottle
with frequent shaking. All the liquid extracts were subjected for physical
analysis and are concentrated in rotary film evaporator and finally dried under
reduce pressure. The residue was weighed and % yield was calculated (Table
no.1). All the extracts were further dried over anhydrous calcium chloride and
preserved in vacuum desiccators for further studies.
Table
No. 1: Physical analysis of liquid
inflorescences extracts and % yield.
Name
of extract |
Colour of extract |
pH |
Fluorescence |
Sp.gr. |
Density |
Viscosity |
yield
of solids (g) |
Nature
of solid extract |
||
D |
S |
L |
||||||||
PEEI |
G |
5.6 |
- |
G |
R |
0.6326 |
0.6457 |
0.6493 |
0.210 |
Waxy |
ChEI |
G |
6.0 |
B |
O |
DB |
1.0896 |
1.1245 |
0.6976 |
0.510 |
Lumpy |
EAEI |
YG |
4.3 |
- |
R |
- |
0.9016 |
0.9827 |
0.5804 |
0.418 |
Powder |
AEI |
B |
5.4 |
- |
RB |
- |
0.7815 |
0.8463 |
0.5649 |
0.321 |
Powder |
MEI |
YB |
5.0 |
- |
G |
PG |
0.8215 |
0.8769 |
0.9684 |
7.17 |
Waxy |
AqEI |
FY |
5.2 |
- |
G |
G |
1.0242 |
1.0565 |
1.0438 |
6.62 |
Powder |
PEEI-Petroleum Ether extract Inflorescence, ChEI-Chloroform Extract Inflorescence, EAEI- Ethyl Acetate
Extract Inflorescence, AEI-Acetone Extract Inflorescence, MEI-Methanol Extract
Inflorescence, AqEI-Aqueous Extract Inflorescence,
Y-Yellow, G-Green, O-Orange, YB-Yellowish Brown, YG-Yellowish Green, B-Brown,
RB-Reddish Brown, R-Red, PG-Pale Green,
FY- Faint Yellow.
Table
No. 2: Phytochemical screening of
inflorescence extracts
Extract |
Sugars |
Alk. |
Tannins |
Glycosides |
steroids |
proteins |
Org.
acids |
|||||||||
R |
NR |
HT |
CT |
a |
c |
s |
f |
co |
ST |
TT |
C |
O |
T |
|||
AqEI |
+ |
+ |
- |
+ |
- |
- |
+ |
+ |
+ |
- |
- |
- |
+ |
- |
+ |
- |
MEI |
+ |
+ |
- |
+ |
+ |
- |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
- |
+ |
- |
EAEI |
+ |
+ |
- |
+ |
+ |
- |
- |
- |
- |
- |
- |
+ |
+ |
- |
+ |
- |
ChEI |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
+ |
+ |
- |
- |
- |
- |
PEEI |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
+ |
+ |
- |
- |
- |
- |
AqEI- Aqueous Extract
Inflorescence, MEI-Methanol Extract Inflorescence, EAEI- Ethyl Acetate Extract Inflorescence, ChEI- Chloroform Extract Inflorescence, PEEI- Petroleum
Ether Extract Inflorescence, Alk-Alkaloids, Gly-Glycosides,
Org. acids-Organic acids, R-Reducing sugars, NR-Non Reducing sugars,
HT-Hydrolysable Tannins, CT-Condensed Tannins, a-anthracene
glycosides, c-Cardiac glycosides, s-saponin
glycosides, f-flavanoidal glycosides, co-coumarin glycosides, + Positive, - Negative.
Phytochemical
screening: All the dried
extracts were dissolved in small quantity of respective solvents and tested for
phytoconsituents using standard reagents and tests24.
The results are given in Table no.2.
Screening of Antimicrobial Activity:
Bacterial
and fungal strains: The
test organisms were purchased from NCIM, NCL Pune.
The organisms were sub-cultured in the media specified. The organisms, their
ATCC code, Media in which they are sub-cultured are given in Table No.3. Bacteria were incubated at 370C in
incubator for 24 h and fungus at 270C for 48 h. They were further
stored at 40C in the refrigerator to maintain stock culture.
Table No. 3: Microorganisms with their ATCC Codes and
media used for subculture
Sr.
No. |
Name
of microorganism |
ATCC
Code |
Media |
1. |
Escherichia coli |
8739 |
Nutrient Agar |
2. |
Bacillus subtilus |
6633 |
Nutrient Agar |
3. |
Micrococcus luteus |
9341 |
Nutrient Agar |
4. |
Pseudomonas aruginosa |
27853 |
Nutrient Agar |
5. |
Staphylococcus aureus |
25923 |
Nutrient Agar |
6. |
Aspergillus niger |
16404 |
Saboraud dextrose agar |
7. |
Candida albicans |
10231 |
Saboraud dextrose agar |
8. |
Penicillium notatum |
28682 |
Saboraud dextrose agar |
a)
Antibacterial Activity 25-28
Preparation
of Media:
Nutrient
Agar: Accurately weighed 28
gm of Nutrient agar (Hi-Media) was dissolved in the 1000 ml of distilled water
by heating with frequent agitation. The media was finally sterilized in
autoclave at 1210C for 15 min.
Preparation
of Test and Standard Drug Solutions:
Preparation
of Test Extracts: All the
five test extracts were prepared freshly by dissolving 1 gm of previously dried
extract in the 10 ml of respective solvent in which they were extracted. This
gives the 100 mg ml-1 of stock solution. From which 0.1 ml was used
for test.
Preparation
of Normal Saline Solution:
Accurately weighed 0.9g sodium chloride was dissolved in 100 ml of distilled
water. Normal saline was sterilized before preparation of microbial suspension
at 1210C for 15 min. in autoclave.
Preparation
of Standard Drug Solutions:
Doxycyclin: Weighed accurately 100 mg doxycyclin,
and dissolved in 100 ml of 0.1M hydrochloric acid to get 1000μg/ml stock
solution. This was then diluted further with distilled water to get solution of
10 µg/ml and 0.1ml was used in well.
Ciprofloxacin:
Weighed accurately 100 mg
ciprofloxacin, and dissolved in 100 ml 0.1 M hydrochloric acid to get 1000 μg/ml stock solution. This was then diluted further
with distilled water to get solution of 10 μg/ml
and 0.1 ml was used in well.
Fluconazole: Weighed accurately 100 mg fluconazole,
and dissolved in 100 ml of dimethyl formamide (DMF) to give 1 mg/ml stock solution. This
solution was further diluted with buffer (which was prepared by dissolving 2g di-potassium hydrogen phosphate and 8 gm potassium dihydrogen phosphate in distilled water to produce 100 ml)
to get solution of 10 µg/ml.Working solution 0.1 ml
of each was used in the well as positive control which will have test
concentration of 1µg each of Doxycyclin,
Ciprofloxacin and Fluconazole in the well.
Sterilization
of Equipments and Media:
Dry
Heat Sterilization: All the
glass wares previously washed were sterilized in hot air oven. Petri-dishes,
pipettes, test tubes were wrapped separately in the paper and kept in the hot
air oven for sterilization at 1800C for 1h.
Moist
Heat Sterilization: Normal
saline solution and nutrient Medias were sterilized in autoclave at 1210C
for 15 min.
Table
No. 4: Antibacterial Activity of Memecylon umbellatum Inflorescences Extracts
Part
of plant |
Sample/
extract |
Conc. used |
Zone of inhibition in mm.* |
||||
E.coli |
P. aeruginosa |
M. luteus |
B. subtilus |
S. aureus |
|||
Control-1 |
2% acacia suspension |
0.2ml |
-- |
-- |
-- |
-- |
-- |
Control-2 |
DMSO |
0.2ml |
-- |
-- |
-- |
-- |
-- |
Standard-1 |
Doxycycline |
01µg |
22 |
18 |
23 |
25 |
23 |
Standard-2 |
Ciprofloxacin |
01µg |
25 |
21 |
27 |
25 |
26 |
Inflorescence |
Pet. ether |
3mg 6mg |
-- -- |
-- -- |
09 10 |
12 14 |
10 11 |
Chloroform |
3mg 6mg |
-- -- |
-- -- |
09 10 |
12 14 |
10 11 |
|
Ethyl acetate |
0.5mg 1.0mg |
25 27 |
-- -- |
16 18 |
20 23 |
22 25 |
|
Acetone |
0.5mg 1.0mg |
09 10 |
-- -- |
10 10 |
-- -- |
10 11 |
|
Methanol |
0.5mg 1.0mg |
21 22 |
-- -- |
20 21 |
18 19 |
18 20 |
|
Aqueous |
3mg 6mg |
15 16 |
-- -- |
-- -- |
11 12 |
16 17 |
*
Average of triplicates
Table
No. 5: Antifungal Activity of Memecylon umbellatum
Inflorescences Extracts
Part of plant |
Sample/ extract |
Conc. used |
Zone of inhibition in mm.* |
||
A.
niger |
C.
albicans |
P.
notatum |
|||
Control-1 |
2% acacia suspension |
0.2ml |
-- |
-- |
-- |
Control-2 |
DMSO |
0.2ml |
-- |
-- |
-- |
Standard |
Fluconazole |
5μg |
16 |
17 |
17 |
Inflorescence |
Pet. ether |
3mg 6mg |
11 12 |
-- -- |
11 12 |
Chloroform |
3mg 6mg |
11 12 |
11 12 |
11 12 |
|
Ethyl acetate |
0.5mg 1.0mg |
11 12 |
11 12 |
14 16 |
|
Acetone |
3mg 6mg |
10 11 |
11 12 |
10 11 |
|
Methanol |
0.5mg 1.0mg |
11 12 |
10 11 |
11 12 |
|
Aqueous |
3mg 6mg |
-- -- |
12 13 |
12 13 |
*
Average of triplicates
Table
No. 5: MIC for Different Memecylon umbellatum
Inflorescences Extracts
Test organisms |
MIC in mg for
different extracts |
|||||
Pet. ether |
Chloroform |
Ethyl acetate |
Acetone |
Methanol |
Aqueous |
|
E.coli |
15 |
15 |
0.5 |
0.5 |
0.5 |
3 |
P.
aeruginosa |
15 |
15 |
1.0 |
15 |
1.0 |
15 |
M.
luteus |
3 |
3 |
0.5 |
0.5 |
0.5 |
7 |
B.
subtilus |
3 |
3 |
0.5 |
7 |
0.5 |
3 |
S.
aureus |
3 |
3 |
0.5 |
0.5 |
0.5 |
3 |
A.
niger |
7 |
3 |
0.5 |
3 |
0.5 |
15 |
C.
albicans |
15 |
3 |
0.5 |
3 |
0.5 |
3 |
P.
notatum |
7 |
3 |
0.5 |
3 |
0.5 |
3 |
Preparation
of Microbial Suspension: Microbial
suspensions were prepared by transferring one loop full of stock culture to the
10 ml of normal saline solution. All the procedure was conducted in the laminar
air flow in aseptic area.
a)
Antibacterial Activity:
Cylinder-Plate or Cup-Plate Method: All the sterilized materials were kept in
the aseptic area in the Ultra-Violet laminar air flow. Bacterial suspensions (3
ml) were then poured in the petriplates. As soon as
nutrient agar attained 500C temperature, 20 ml was poured in to the petriplates containing bacterial suspension and plates were
rotated to mix the suspension with media. When the agar got solidified bores
were made in the plate with sterile borer of 8 mm diameter. In each plate six
bores were made. Out of which one is meant for addition of standard, two for
negative control of blank solvents of standard and sample and remaining three
bores for addition of same concentrations of sample. 0.1 ml of sample was added
in each cylinder. The plates were kept to allow diffusion at room temperature
for three hours and then incubated in the upright position in incubator at 370C
for about 21 h for bacterial growth. The diameter of zone of inhibition was
accurately measured for bacterial growth in each treated plate as shown in
Table No.4. The zone of inhibition of bacterial growth by the test solution was
compared with the zone of inhibition by the standard at tested concentrations.
b)
Antifungal Activity:
For fungus,
SDA (Saboraud Dextrose Agar) was poured in the petriplates, allowed to solidify. The fungal suspensions
were then sprayed uniformly over the surface of agar. All the procedure was
same as that of for antibacterial activity. Fungi were incubated at room
temperature for 48h. Zone of inhibitions of fungal growth were recorded as
shown in Table No. 5.
Determination
of MIC:
Promising extracts were tested for MIC using
serial broth dilution technique29. 10 ml of sterile nutrient broth
without agar was taken in a test tube and concentrations of 0.5, 1, 3, 7, 15 mg
of test samples were added aseptically. 1 ml of inoculum
of each test organism in normal saline (105 CFU) was added in each
sample. The tubes were incubated at 37°C for 24 h (or 48 h for the fungi) and
then observed for the Minimum Inhibitory Concentration (MIC). The growth of
organisms was observed as turbidity determined by a double beam
spectrophotometer (Jasco V-530) at 620 nm. Control
tubes without the tested extracts were assayed simultaneously. All samples were
tested in triplicate and results are given in table no. 6.
RESULT AND
DISCUSSION:
The yield was found maximum for
methanol and minimum for light petroleum. Polar extracts showed presence of
tannins glycosides sugars and organic acids while non polar extracts showed
steroids and triterpens. Ethyl acetate and methanol
extracts have shown better antimicrobial activity compare to other extracts.
All the extracts failed to show activity against P.
aeruginosa.
Petroleum ether and chloroform extracts exhibited activity at higher
concentration (3mg) compare to ethyl acetate and methanol (0.5mg). The activity
shown by ethyl acetate was comparable with standards at tested concentrations.
MIC for ethyl acetate and methanol was found to be 0.5mg for the entire
organism except P. Aeruginosa (1mg) compare to 3-15mg for other extracts. Acetone and aqueous
extracts also showed antimicrobial activity but at higher concentrations (3
-15mg). Different extracts showed presence of tannins, glycosides, triterpens and steroids as important constituents. These
constituents may be responsible for antimicrobial activity as per the reported
activities such as Camellia sinensis,20 Rhizophora apiculata bark,21 blue and white flowering Silybum
marianum,22 roots of Tecoma
stans,23 punicalagin
from the peel of Punica granatum,
tannic acid from galls and prodelphinidin oligomers from the bark of Elaeocarpus
sylvestris var. ellipticus
etc.24.
Further study is necessary to isolate the constituent responsible for activity
from ethyl acetate and methanol extracts.
REFERENCES:
1.
Tomoko N,
Takashi A, Hiromu T, Yuka I, Hiroko M, et al. Antibacterial activity of extracts preparated from tropical and subtropical plants on methicillin-resistant Staphylococcus aureus. J. Health Sci. 48; 2002: 273–276.
2.
Sieradzki
K, Roberts RB, Haber SW, Tomasz A. The development of vancomycin
resistance in a patient with methicillin-resistant Staphylococcus
aureus infection. N. Engl. J. Med. 340; 1999: 517–523.
3.
Ghani
A, Abdulrahman EM, Onaolapo
JA. Chemical and microbiological evaluation of some Nigerian traditional
preparations. The Rep. Oct. 7. 1989.
4.
Robbers J, Speedie M, Tylor V. Pharmacognosy
and Pharmacobiotechnology. Williams and Wilkins,
Baltimore. 1996. pp. 1-14.
5.
Iwu
MW, Duncan AR, Okunji CO. New antimicrobials of plant
origin. In Janick J. (ed.): perspectives on new crops
and new uses. ASHS Press, Alexandria, VA:
1999. 457-462.
6.
Castello MC, Anita P, Naresh C, Madhuri S.
Antimicrobial activity of crude extracts from plant parts and corresponding cali of Bixa orellina. Ind. J. Exper.
Biol. 40; (2002): 1378- 1381.
7.
Shajahan A, Ramesh S. Antimicrobial activity of crude ectocarp extract of Pomegranate (Punica
granatum L.) against some selected enteropathogenic bacteria. As. J. Microbiol.
Biotech. Env. Sci. 6(4); 2004: 647-648.
8.
Kirtikar KR and Basu BD. Indian Medicinal Plants. Popular Prakashan, New Delhi. 1996. p.1063-67.
9.
Nadkarni KM, Indian Materia Medica. Bombay Prakashan. Bombay. 1982. p. 787.
10.
Sastri BN, The Wealth of
India, Publication and Information Directorate, CSIR, Hillside, New Delhi,
India, 1962. p.336.
11.
Dhar ML, et al.,
Screening of Indian plants for biological activity, Part 1, Indian J. Exp.
Biol. 2; 1968: 232-247.
12.
Amalraj T and Ignacimuthu S, Evaluation of hypoglycemic effect of Memecylon umbellatum in
normal and alloxan diabetic mice. J Ethanopharmacol., 62, 1998, 247-250.
13.
Joshi H. et al., Hypoglycemic effect of Memecylon umbellatum root,
PHCOG MAG. 15; 2008: 1-4.
14.
Puratchikody and Naglakshmi G, Wound healing activity of Memecylon
umbellatum burm. J
Plant Sci. 2; 2007: 179-186.
15.
Joshi Himanshu et al.
Evaluation of antipyretic potential of Memecylon
umbellatum root extract, Indian J. Nat. Prod., 25
(1); 2009: 13.
16.
Killedar S.G., More H.N. Analgesic and anti-Inflammatory studies of Memecylon umbellatum Burm roots in experimental animals. Research J. Pharm. and Tech. 2(4); 2009:
858-861.
17.
Joshi Himanshu et al., Hepatoprotective activity of Memecylon umbellatum roots
against acetaminophen induced hepatotoxicity in rats.
J. Res. Educ. Indian Med. 14 (2); 2008:
49-54.
18.
Killedar S.G., More H.N. Anthelmintic and anti-Insect activities of Memecylon umbellatum Burm root extracts. Research J. Pharmacology and Pharmacodynamics 2(1); 2010: 54-58.
19.
Ram PR and Mehrotra BN,
Compendium of Indian Medicinal Plants, (Drug Research Preparative: A CDRI
Series), Vol. 2, Central Drug Research Institute, Lucknow
and Publications and Information Directorate, New Delhi.1993. p.453.
20.
Asolkar LV, Kakkar KK and Chakre OJ, Glossary
of Indian Medicinal Plants with active principal, part-I, Publications and
Information Directorate, Council of Scientific and Industrial Research Publ.
New Delhi.1956. p.165.
21.
Peach EK, Tracy MV, Modern Methods of Plant Analysis,
Springer Verlag Publication, Vol-III,
1915.p. 332-350.
22.
Harborne JB. A guide to
Modern Techniques of Plant Analysis. Chapman and Hall, London.1973.
23. British
Pharmacopoeia. Appendix XID A153 Vol. II
London HMSO. 1993.
24.
Khandelwal KR. Practical Pharmacognosy -Techniques and Experiments. 18th ed.
Nirali Prakashan, Pune. 2007. p. 149-156.
25.
Mahmood AM and Ameh JM., African Journal of
Biotechnology. 6(11); 2007: 1272-1275.
26.
Manish BT and Rema Subhash. Tropical Journal of
Pharmaceutical Research. 5(1); 2006: 557-560.
27.
Jigna Parekh and Sumitra Chanda. Brazilian Journal
of Microbiology. 38: 2007: 204-207.
28.
Govt. of India Ministry of Health and family welfare,
Indian Pharmacopoeia, vol. II, 1996; A-100- 124.
29.
Dagmar Janovska, Katerina Kubikova and Ladislav Kokoska. Screening for antimicrobial activity of some medicinal plants species of
traditional Chinese medicine. Czech J. Food Sci. 21(3);
107–110
30. Hamilton-Miller JMT. Antimicrobial properties of Tea (Camellia sinensis L.); Antimicrobial Agents and
Chemotherapy, London. United Kingdom.
Nov. 1995. p. 2375–2377.
31. Lim SH, Darah I and Jain K.
Antimicrobial activities of tannins extracted from Rhizophora
Apiculata bark; Journal of Tropical Forest Science Malaysia. 18(1);2006: 59-65.
32. Muhammad Syed, Shah Mukarram, Khan Farhat Ali et al. Evaluation of phytochemicals
and antimicrobial activity of white and blue capitulum
and whole pant of Silybum marianum. World Applied Sciences Journal Peshawar.
Pakistan. IDOSI Publications.12 (8); 2011: 1139-1144.
33. Govindappa M, Sadananda TS, Channabasava R, Jeevitha MK et al., Antimicrobial and
antioxidant activity and phytochemical screening of Tecoma
stans; Journal of Phytology Phytopharmacology. 2011: 68-76.
34. Toshitsugu Taguri, Takashi Tanaka, and Isao Kouno. Antimicrobial
activity of 10 different plant polyphenols against
bacteria causing food-borne disease. Biol. Pharm. Bull. 2004: 1965-1969.
Received on 15.10.2011 Accepted on 23.11.2011
© Asian Pharma
Press All Right Reserved
Asian J. Pharm.
Res. 1(4): Oct. - Dec. 2011;
Page 114-118